These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 3783447)

  • 1. A dispersion model of hepatic elimination: 2. Steady-state considerations--influence of hepatic blood flow, binding within blood, and hepatocellular enzyme activity.
    Roberts MS; Rowland M
    J Pharmacokinet Biopharm; 1986 Jun; 14(3):261-88. PubMed ID: 3783447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A dispersion model of hepatic elimination: 1. Formulation of the model and bolus considerations.
    Roberts MS; Rowland M
    J Pharmacokinet Biopharm; 1986 Jun; 14(3):227-60. PubMed ID: 3783446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dispersion model of hepatic elimination: 3. Application to metabolite formation and elimination kinetics.
    Roberts MS; Rowland M
    J Pharmacokinet Biopharm; 1986 Jun; 14(3):289-308. PubMed ID: 3783448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Models of hepatic drug clearance: discrimination between the 'well stirred' and 'parallel-tube' models.
    Ahmad AB; Bennett PN; Rowland M
    J Pharm Pharmacol; 1983 Apr; 35(4):219-24. PubMed ID: 6133930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic clearance of drugs. I. Theoretical considerations of a "well-stirred" model and a "parallel tube" model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance.
    Pang KS; Rowland M
    J Pharmacokinet Biopharm; 1977 Dec; 5(6):625-53. PubMed ID: 599411
    [No Abstract]   [Full Text] [Related]  

  • 6. A new model-independent physiological approach to study hepatic drug clearance and its applications.
    Chiou WL
    Int J Clin Pharmacol Ther Toxicol; 1984 Nov; 22(11):577-90. PubMed ID: 6389376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting Clearance with Simple and Permeability-Limited Physiologically Based Pharmacokinetic Frameworks: Comparison of Well-Stirred, Dispersion, and Parallel-Tube Liver Models.
    Nagar S; Parise R; Korzekwa K
    Drug Metab Dispos; 2024 Sep; 52(10):1060-1072. PubMed ID: 39084881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Commentary: a physiological approach to hepatic drug clearance.
    Wilkinson GR; Shand DG
    Clin Pharmacol Ther; 1975 Oct; 18(4):377-90. PubMed ID: 1164821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered hepatic blood flow and drug disposition.
    Nies AS; Shand DG; Wilkinson GR
    Clin Pharmacokinet; 1976; 1(2):135-55. PubMed ID: 13954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the influence of protein binding on pharmacological activity of drugs.
    Berezhkovskiy LM
    J Pharm Sci; 2010 Apr; 99(4):2153-65. PubMed ID: 19827100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic clearance concepts and misconceptions: Why the well-stirred model is still used even though it is not physiologic reality?
    Pang KS; Han YR; Noh K; Lee PI; Rowland M
    Biochem Pharmacol; 2019 Nov; 169():113596. PubMed ID: 31398312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The series-compartment model for hepatic elimination.
    Gray MR; Tam YK
    Drug Metab Dispos; 1987; 15(1):27-31. PubMed ID: 2881755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discussions on the hepatic well-stirred model: Re-derivation from the dispersion model and re-analysis of the lidocaine data.
    Dong J; Park MS
    Eur J Pharm Sci; 2018 Nov; 124():46-60. PubMed ID: 30102979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Model independent derivation of general equations for the "first-pass" effect and extra-hepatic drug elimination.
    Vaughan
    Eur J Clin Pharmacol; 1977; 11(1):57-64. PubMed ID: 832659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clearance and biologic half-life as indices of intrinsic hepatic metabolism.
    Perrier D; Gibaldi M
    J Pharmacol Exp Ther; 1974 Oct; 191(1):17-24. PubMed ID: 4423599
    [No Abstract]   [Full Text] [Related]  

  • 16. Availability predictions by hepatic elimination models for Michaelis-Menten kinetics.
    Roberts MS; Donaldson JD; Jackett D
    J Pharmacokinet Biopharm; 1989 Dec; 17(6):687-719. PubMed ID: 2635740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A nonlinear physiologic pharmacokinetic model: I. Steady-state.
    Wagner JG; Szpunar GJ; Ferry JJ
    J Pharmacokinet Biopharm; 1985 Feb; 13(1):73-92. PubMed ID: 4020623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between in-vitro microsomal enzyme activity and whole organ hepatic elimination kinetics: analysis with a dispersion model.
    Roberts MS; Rowland M
    J Pharm Pharmacol; 1986 Mar; 38(3):177-81. PubMed ID: 2871151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein Binding and Hepatic Clearance: Re-Examining the Discrimination between Models of Hepatic Clearance with Diazepam in the Isolated Perfused Rat Liver Preparation.
    Wang HJ; Benet LZ
    Drug Metab Dispos; 2019 Dec; 47(12):1397-1402. PubMed ID: 31563869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane transport in hepatic clearance of drugs. I: Extended hepatic clearance models incorporating concentration-dependent transport and elimination processes.
    Kwon Y; Morris ME
    Pharm Res; 1997 Jun; 14(6):774-9. PubMed ID: 9210196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.